Search Results 1171-1180 of 24178 for Renal
... renal allografts. Hum Immunol. 2006 Oct; 67 (10):777-86 Epub 2006 Aug 04. View PubMed; Du ZY, Li XY, Li YC, Wang SY. Analysis of triptolide-regulated gene ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD ...
FellowMolecular Genetic Pathology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine. 2021. FellowRST Renal ...
... renal parenchymal diseases. Publications. See a list of publications about chronic kidney disease by Mayo Clinic doctors on PubMed, a service of the National ...
... Renal artery stenting, Renal artery endarterectomy, Aneurysm surgery, Renal artery bypass, Renal artery angioplasty, Celiac artery bypass, Carotid artery ...
... Renal artery stenting, Renal artery endarterectomy, Arteriovenous malformation surgery, Aneurysm surgery, Renal artery bypass, Renal artery angioplasty ...
Rapidly progressive reduction in renal function characterized by. SCr ≥ 2.5 mg/dL; Doubling of SCr within 2 weeks (or for observations of shorter duration ...
This research, supported in part by the Mayo Clinic Center for Regenerative Medicine, provides a foundation on which someday patients with end stage renal ...
The purpose of this study is to assess the serum potassium and cardiac rhythm trends in subjects with end stage renal disease (ESRD) who are on 3 times ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!